搜尋結果
Investor Neil Hennessy says megacap tech trade is 'over' and to buy these two stocks instead
CNBC· 18 小時前Neil Hennessy said investors need to look at value stocks that offer attractive price-to-sales ...
Morning Bid: Rate angst creeps back; yuan, yen weaken anew
Reuters· 23 小時前The surprise unnerved money markets and saw futures shift the chances ...
An S&P 500 10% correction is likely this summer, says Piper Sandler
CNBC· 19 小時前It's time to heed the warning signs in markets, according to Piper Sandler. Craig ... ...
Grail's shares fall in Nasdaq debut after spin-off from Illumina
Reuters· 12 小時前As an independent company, Grail is betting on commercial partnerships with health systems, ...
Why Apple's focus on AI privacy could help fuel the next iPhone upgrade cycle
CNBC· 17 小時前Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" ...
FedEx climbs on cheery annual profit forecast, freight business review
Reuters· 22 小時前On Tuesday, the company projected fiscal 2025 earnings of $20 to $22 per share - & ...
Announcing the agenda for the Fintech Stage at TechCrunch Disrupt 2024
TechCrunch· 18 小時前As the fintech industry evolves, new opportunities abound for founders, investors, and customers. Areas ...
Rainforest lands $20M to challenge Stripe with embedded payments for SaaS providers
TechCrunch· 20 小時前Rainforest, a startup that embeds payment processing into other software platforms, has raised ...
Wegovy weight-loss drug OK'd in China
China Daily· 24 小時前Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where ...